Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 3

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × SB939 compound × Clear all
NCT01075308 2023-08-04

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

Canadian Cancer Trials Group

Phase 2 Completed
32 enrolled
Genitourinary

Prostatic Neoplasms

NCT01912274 2021-02-09

Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Helsinn Healthcare SA

Phase 2 Completed
50 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02267278 2019-06-12

Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)

M.D. Anderson Cancer Center

Phase 2 Completed
25 enrolled 8 charts
Myeloid

Polycythemia Vera, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡